Antiretroviral therapy (and resulting increased viral suppression) linked to longer AND healthier lives for older adults in South Africa

HAALSI men and women

Researchers affiliated with the HAALSI study, including former Harvard Bell Fellows Collin Payne, PhD, and Lindsay Kobayashi, PhD, and faculty member Jennifer Manne-Goehler, PhD, are among the authors of a study published in The Lancet HIV that links increased viral suppression at the population level with not only increased life expectancy, but also with less disability, pointing to the value of ART to foster healthy aging. Learn more in this…

Study of aging population in South Africa finds that HIV viral suppression through ART is leveling the field of healthy longevity

HAALSI men and women

Findings by HAALSI researchers published in The Lancet Healthy Longevity, a special issue of conference abstracts, point to similar levels of increased lifespan and “healthspan” among those HIV-positive individuals who achieved viral suppression through ART as observed among HIV-negative individuals.

Immediate eligibility of ART lowers household-level incidence of HIV by over 40%

A study finds that early eligibility of antiretroviral therapy substantially lowered HIV incidence among HIV-uninfected household members in rural South Africa. The team of researchers who published the findings includes Harvard Pop Center faculty members Drs. Kenneth Mayer and Till Bärnighausen, as well as visiting scientist Guy Harling.

Receiving antiretroviral therapy for HIV may offer spillover health benefits for at-risk population in South Africa

Two older women walk on a dirt road in rural South Africa

A team of HAALSI (a research project studying health of aging population in South Africa) researchers affiliated with the Harvard Pop Center has found that HIV-positive adults in South Africa who receive antiretroviral therapy (ART) for HIV have greater access to preventative care for non-communicable diseases (NCDs) such as diabetes and hypertension. Their findings are published in the journal Open Forum Infectious Diseases.